Franz Humer

Franz Humer

Director/Board Member at ALLOGENE THERAPEUTICS, INC.

Net worth: 832 995 $ as of 30/08/2024

77 year
Finance
Health Technology
Technology Services

Profile

Franz B. Humer is an Austrian businessperson who has been the head of 13 different companies and currently is Chairman at Friends of Phelophepa Foundation, Co-Chairman for Packaging Coordinators, Inc., Executive Chairman for Neogene Therapeutics, Inc., Chairman of Hmnc Brain Health GmbH and Venture Partner & Senior Advisor at Pappas Capital LLC. Dr. Humer is also Chairman of The International Centre for Missing & Exploited Children, Chairman for Humer Foundation and Member of European Round Table of Industrialists and on the board of 7 other companies. In his past career Franz B. Humer occupied the position of Non-Executive Chairman of Roche Holding AG Chairman at Roche Holdings, Inc. and Chief Operating Officer of F. Hoffmann-La Roche Ltd. (both are subsidiaries of Roche Holding AG), Chairman at Diageo Plc, Director at Jacobs Holding AG, Chairman & Chief Executive Officer at Roche Group, Chairman for PCI Services Ltd., Managing Director at Glaxo Pharmaceuticals UK Ltd., Chief Operating Director at Glaxo Holdings Plc, General Manager for Schering-Plough Corp., General Manager of Schering-Plough Ltd., Managing Director at Glaxo Wellcome UK Ltd., Chairman of INSEAD and Principal at European Federation of Pharmaceutical Industries & Assns. He received an MBA from INSEAD and a doctorate from the University of Innsbruck.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
04/06/2024 316,728 ( 0.15% ) 832 995 $ 30/08/2024

Franz Humer active positions

CompaniesPositionStart
ALLOGENE THERAPEUTICS, INC. Director/Board Member 31/03/2018
Consultant / Advisor 30/11/2013
Director/Board Member -
Chairman -
Chairman -
Chairman -
Director/Board Member -
Director/Board Member -
Director/Board Member 31/12/2014
░░░░ ░░░░ ░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
All active positions of Franz Humer

Former positions of Franz Humer

CompaniesPositionEnd
░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Franz Humer's experience

Training of Franz Humer

University of Innsbruck Doctorate Degree
INSEAD Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Franz Humer's experience

Connections

100 +

1st degree connections

45

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies8
DIAGEO PLC

Consumer Non-Durables

ROCHE HOLDING AG

Health Technology

CITIGROUP INC.

Finance

ALLIANZ SE

Finance

WISEKEY INTERNATIONAL HOLDING AG

Electronic Technology

ARIX BIOSCIENCE PLC

Finance

CHUGAI PHARMACEUTICAL CO., LTD

Health Technology

ALLOGENE THERAPEUTICS, INC.

Health Technology

Private companies34
Glaxo Holdings Plc

Finance

Consumer Non-Durables

Health Technology

Health Technology

European Round Table of Industrialists

Friends of Phelophepa Foundation

Commercial Services

Finance

Finance

Humer Foundation

Health Technology

Health Technology

Health Technology

Health Services

Finance

Finance

Health Technology

Health Technology

Technology Services

Technology Services

Emil Frey SA Genève

Finance

Technology Services

Finance

Finance

Health Technology

Glaxo Pharmaceuticals UK Ltd.

Technology Services

Health Technology

Health Technology

Finance

Finance

Retail Trade

Health Services

See company connections
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW